3LSL
Piracetam bound to the ligand binding domain of GluA2 (flop form)
Summary for 3LSL
| Entry DOI | 10.2210/pdb3lsl/pdb |
| Related | 3LSF 3LSW 3LSX |
| Descriptor | Glutamate receptor 2, GLUTAMIC ACID, 2-(2-oxopyrrolidin-1-yl)acetamide, ... (5 entities in total) |
| Functional Keywords | glutamate receptor, glur2, glua2, ampa receptor, neurotransmitter receptor, s1s2, allosteric modulator, alternative splicing, cell junction, cell membrane, endoplasmic reticulum, glycoprotein, ion transport, ionic channel, membrane, phosphoprotein, postsynaptic cell membrane, receptor, rna editing, synapse, transmembrane, transport, transport protein |
| Biological source | Rattus norvegicus (brown rat,rat,rats) More |
| Cellular location | Cell membrane; Multi-pass membrane protein: P19491 |
| Total number of polymer chains | 3 |
| Total formula weight | 88553.80 |
| Authors | Ahmed, A.H.,Oswald, R.E. (deposition date: 2010-02-12, release date: 2010-03-16, Last modification date: 2024-11-06) |
| Primary citation | Ahmed, A.H.,Oswald, R.E. Piracetam Defines a New Binding Site for Allosteric Modulators of alpha-Amino-3-hydroxy-5-methyl-4-isoxazole-propionic Acid (AMPA) Receptors. J.Med.Chem., 53:2197-2203, 2010 Cited by PubMed Abstract: Glutamate receptors are the most prevalent excitatory neurotransmitter receptors in the vertebrate central nervous system and are important potential drug targets for cognitive enhancement and the treatment of schizophrenia. Allosteric modulators of AMPA receptors promote dimerization by binding to a dimer interface and reducing desensitization and deactivation. The pyrrolidine allosteric modulators, piracetam and aniracetam, were among the first of this class of drugs to be discovered. We have determined the structure of the ligand binding domain of the AMPA receptor subtypes GluA2 and GluA3 with piracetam and a corresponding structure of GluA3 with aniracetam. Both drugs bind to GluA2 and GluA3 in a very similar manner, suggesting little subunit specificity. However, the binding sites for piracetam and aniracetam differ considerably. Aniracetam binds to a symmetrical site at the center of the dimer interface. Piracetam binds to multiple sites along the dimer interface with low occupation, one of which is a unique binding site for potential allosteric modulators. This new site may be of importance in the design of new allosteric regulators. PubMed: 20163115DOI: 10.1021/jm901905j PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.122 Å) |
Structure validation
Download full validation report
